GROWING MEDICAL DEVICE SALES

WITH OUTSTANDING COMPLIANCE & COMMERCIAL EXPERTISE

Asia Actual provides customized market access solutions through registration, independent license holding, and importing support services to medical device manufacturers including novel and high risk devices.

We distinguish ourselves with (1) outstanding personnel; (2) clear communication; and  (3) transparent operations. We have offices staffed by experienced, bilingual regulatory and commercial professionals in the major capital cities of Asia.

Our mission is to provide a stable, reliable local platform so that our clients can grow their sales in challenging Asian markets.

Let Us Help You Grow Your Sales.

Speak to a Local Regulatory Professional Today

Meet our Experts

BRYAN GILBURG

MANAGING DIRECTOR
(USA)

GUNJAN VERMA

MANAGING PARTNER
(INDIA)

ILHAM HIDAYATTULAH

PRINCIPAL CONSULTANT
(INDONESIA)

CHARMAINE ROSON

PRINCIPAL CONSULTANT
(PHILIPPINES)

Glend Llantada

IMPORTATION SPECIALIST
(SOUTHEAST ASIA)

SAYOOMPORN (NOI) SUWANNABOT

GENERAL MANAGER
(THAILAND)

ERIC LEUNG

GENERAL MANAGER
(HONG KONG AND TAIWAN)

SARAH BAIK

PRINCIPAL CONSULTANT
(KOREA)

DAVID VO

GENERAL MANAGER
(VIETNAM)

KENNA RASIKLAL

PRINCIPAL CONSULTANT
(SINGAPORE)

ALBERT PRANOTO

HEAD OF BUSINESS DEVELOPMENT - ASIA (SINGAPORE)

The future is bright.

Asia Actual’s innovative approach of leveraging regulatory compliance to create novel sales channel management tools has made us the fastest growing consultancy in the region. The formula is a winning one. Come grow with us.

We represent over 100 Dynamic companies from 20 Countries
with over

1,000 registered products

to date

Search Our Regulatory Knowledge

Recent News from Asia

China’s NMPA Updates Medical Device Classification Catalogue

China’s National Medical Products Administration (NMPA) maintains a list of all medical device categories called the Medical Device Classification Catalogue. NMPA published a notice on August 17, 2023, that they had released amendments to the Medical Device Classification Catalogue. It’s important for manufacturers to understand these changes as they can significantly impact the cost and time to register medical devices.

Thai FDA Drafting New Guidance for SaMD and AI Device Registration

Thai FDA is drafting new guidelines for AI Regulation. The novel characteristics of artificial intelligence (AI) software cause issues with the medical device registration process in most countries. The Thai Food and Drug Administration (Thai FDA) is working to address this important issue, most recently by hosting a meeting with interested parties on July, 2023, which Asia Actual Thailand employees were invited to attend.

China NMPA Adds 47 Products to Clinical Trial Exemption List

China’s National Medical Products Administration (NMPA) updated its clinical trial exemption list, adding 47 products. The NMPA updates this list every two to three years, with the last amendment in 2021. This brings the total number of clinical trial exempted product categories in China to 1,025.

Check Out Our New Tool to Search

Registered Device Licenses in Asian Markets

Sign Up For Our Newsletter to Stay Informed

Sign Up